Showing posts with label ethics. Show all posts
Showing posts with label ethics. Show all posts

Thursday, March 1, 2012

Pfizer Groton Occupied



Video from Occupy Shoreline CT.org 
http://occupyshorelinect.org/content/f29-pfizer-alec-protest-groton-ct#comments

Close to one hundred people in Connecticut gathered on March 29, 2012 to protest Pfizer in front of their large facility in Groton, Connecticut.  Pfizer, the largest pharmaceutical company in the world, is a member of a controversial group called the American Legislative Exchange Council (ALEC).  ALEC aligns with government and legislators to make laws that unfairly favor corporations over working people. 

This protest at Pfizer Groton was one of many protests all over the nation against Pfizer by Occupy Wallstreet groups.  Pfizer which made more than $68 billion in business last year was recently cited for a $2.3 billion settlement  for repeat offenses of illegal off-label marketing of their drugs to make extra profits.  Under a federal law, Pfizer was supposed to be excluded from selling drugs within Medicare because of their serious repeated criminal acts of fraud.  Pfizer, however, was later classified as "too big to nail" and was not penalized allowing them to participate within Medicare without restrictions.

While Pfizer was not prosecuted to the fullest extent for crossing the line of legal and ethical standards, eight people during the protest were alleged to have crossed Pfizer-police lines and were arrested at Groton Pfizer.  They were cited for first degree criminal trespass.  These eight people, acting on behalf of the 99%, were Alex Suarez, Danielle Digirolamo, Ashley Gillece, Cassandra Johnson, James Crombie, Joshua Heltke, Gregory Walker and Erin Mitchell.  Unlike Pfizer which is "too big to nail", these citizens were apparently "too small and got nailed".

People around the nation continue to protest against corporations like Pfizer and members of ALEC.  These bad corporate actors take actions and make laws that are not on the working people's side.

Other links:
http://www.theday.com/article/20120301/NWS01/303019537/1017

Video from Occupy Shoreline CT.org

http://occupyshorelinect.org/content/f29-pfizer-alec-protest-groton-ct#comments



Wednesday, June 8, 2011

Monday, May 23, 2011

Leadership, Power and Women

Leadership, Power and Women

Becky A. McClain

November 21, 2009

I find it ironic that in a crowded room full of women who had been lured to a talk entitled “Stepping into Power: How to Get it and How to Use It”, the lone person dozing off at the event was the only man in attendance.

Sponsored by a professional women networking group called the Lower Connecticut Valley Branch of the American Association of University Women (AAUW), the public event last Wednesday held in Old Saybrook’s Acton Library featured Dr. Nancy Hutson, a 25 year career Pfizer executive who had retired in 2006.

Hutson’s talk was advertized to discuss the subject of POWER – getting it and how to use it in the context of her experience as a woman during her career climb from a bench scientist to Senior Vice President in the male-dominated pharmaceutical organization at Pfizer Inc.

I was intrigued, not only because of the topic of power and how it relates to working women, but also, because of the past history of Pfizer and their use of power.

You see, Pfizer has not displayed the best reputation for getting and using power. In fact, Pfizer’s reputation has become seriously tarnished this past decade both locally and internationally. Their role in the imminent domain take over of New London homes, and subsequently bugging out of New London after their 10 year tax incentive deal expired, their role in public health and safety violations accompanied with research building explosions causing serious injuries, their role in unethical clinical trials resulting in deaths of Nigerian children, and finally, their egregious behavior in criminal fraud against the government for promotion of off-labeled use of their drugs are some of Pfizer’s most recent notorious acts, costing the company billions of dollars in criminal fines and settlements.

So how was Hutson going to deliver her topic on the use of power in light of what some could allege was a grand collection of abuse of power from Pfizer during her tenure?

But Hutson was slick to avoid such topics, as any savvy executive would.

And in the end her talk was disappointingly empty. Not only in her uncanny assertion that Pfizer’s bad reputation resulted from healthcare reform, baby boomers and bad economy, but also for her bland subject matter relating to power, women and the her workplace experiences.

One would think that a woman who has climbed the corporate ladder of success at Pfizer from bench scientist to Senior Vice President in charge of 4500 Groton scientists would have SOME gripping stories to share, stories containing her trials and tribulations of being a woman within the highly charged political terrain of a male dominated pharmaceutical industry.

But Hutson’s worst experience shared with us was the time her supervisor performed email tasks while she was trying to have a discussion with him. Apparently her supervisor was not being completely “present” with her, making her feel discounted.

It was then when I turned to my side and noticed my husband beginning to nod off. And as I dug my elbow into his side to make him “be present”, I realized that Hutson did not even bother to tell us how she resolved the dilemma of having such a multi-tasking un-present supervisor.

Matter a fact, Hutson gave us very little insights about the true struggles women face in the workplace, like harassment, discrimination, glass ceilings, managing work and family, and unequal pay scales.

Instead she gave us an ordinary package of self-help steps to leadership, wrapped in jargon, ringing of mundane familiarity, …“Develop relationships”, “be present”, “manage your energy”, “practice leadership”, “have defined purpose, mission and goals”. Abracadabra. You’ve got power.

And of course, not a whisper of ethics. Hutson’s experience with ethics at Pfizer apparently had little connection in defining her steps in how to get power and use it.

Despite Hutson’s cookbook and carefully constructed talk, what was apparent, however, was at the conclusion of her presentation, you could not help but like Nancy Hutson.

And that’s because Hutson fits the part.

Nancy Hutson fits the part of our present day executives, people who look and act intelligent, self assured, but down to earth, and who have the ability to develop relationships because of their knack for the art of massaging communication. They are the type of person you seemingly could trust with any personal issue, a person that one would love to share a cup of coffee and perhaps become friends.

But in reality, many corporate execs who have “stepped into power” have often watched unethical practices unfold in their businesses. And while “practicing leadership”, standing composed and smiling, carefully managing their energy and their speech, they do nothing, as well as, say nothing about these unethical practices.

You see, good executives deliver for their corporations, reporting to the bottom line. And that is exactly what Hutson told us on Wednesday. One of her opening statements was that her career role shifted from bench science to politics and the bottom line. Hutson went on to say that those who deliver for corporations are rewarded by power, title and money.

Hutson surely delivered at this talk at the AAUW meeting. She was intelligent, articulate and friendly. She gave a well structured talk, avoiding Pfizer’s history of ethical troubles.

But a discussion about leadership and power, without involving ethics, sells cheap. It holds no real substance for the majority of professional women of Connecticut who want to succeed while making the world a better place. And ironically, it put the only man attending such a discussion, right to sleep.



Sunday, January 9, 2011

AMA Against Injured Workers

The AMA has produced a new guide to disabilities that dramatically reduces aid to injured workers.  The new guide is surrounded with controversary and lack of transparancy.  Congress has called it into question, but AMA officials refused to attend the congressional conference to answer questions

"Workers' compensation is sometimes called "the Grand Bargain." Under workers' comp, employees give up their right to sue their bosses for workplace injuries and illnesses in exchange for compensation under a no-fault system. As Rep. Lynn Woolsey (D-CA) said at a Nov 17 subcommittee hearing of the House Education & Labor Committee, this grand bargain of the 20th Century doesn't seem so grand these days. Benefits for injured workers have declined significantly since the 1990s because of intensive state-level lobbying by insurers and self-insured employers. The latest guidelines for assessing workplace health issues may depress benefits even further."


"The primary focus of the hearing was the sixth and latest edition of the American Medical Association's Guides to the Evaluation of Permanent Impairment, the bible for determining how a workplace health problem translates into on-the-job impairment. This may sound like an obscure issue, but the answers potentially affect millions of American workers. Many states require the use of the latest edition of the Guides, the 6th Edition, published in 2007, has proved so controversial that some states, including Iowa, Kentucky and Vermont, have chosen not to adopt it."

"Rep. Woolsey alleged in her opening statement that the latest edition of the guide has "dramatically reduced impairment ratings for many types of conditions, without apparent medical evidence, and transparency." Various witnesses echoed Woolsey's assessment that the 6th Edition is dramatically different from previous editions."


"It also appears that the 6th edition was developed in near secrecy, without the transparency and consensus which should necessarily accompany the development of standards that will have widespread use by state governments," she added."

"Godfrey testified that the AMA declined to disclose the names of the authors of chapters in the guide to an Iowa Workers Compensation task force in 2008. As of this week, neither the Iowa Division of Workers Compensation, nor the Workforce Protections Subcommittee had received a list of chapter authors.

The AMA was invited to send a representative to testify at the Nov 17 hearing, but the Association declined to do so and instead submitted written comments for the record."

For complete article:
http://inthesetimes.com/working/entry/6728/congress_asks_tough_questions_about_ama_disability_bible/

Friday, August 6, 2010

Vatican Radio_Human Trial on Embryonic Stem Cell is a Crime

Human trials for embryonic stem cell treatment a crime, says Bishop Sgreccia

Posted August 3, 2010

Rome, Italy, (CNA/EWTN News).- Following Friday’s news that a U.S. company has been given the go ahead to experiment with embryonic stem cells on human patients, a former head of the Pontifical Academy for Life told Vatican Radio that the trials are unacceptable. He said that regardless of whether the result of testing is positive or negative, “morally it remains a crime.”

Biopharmaceutical developer Geron, which has its headquarters in California, announced last Friday that it was cleared by the U.S. Food and Drug Administration (FDA) to begin testing injections of an embryonic stem cell derivative in treatments for severe spinal-cord injuries.

Geron celebrated the FDA’s approval which, they said, gives them the ability to legally “move forward with the world’s first clinical trial of a human embryonic stem cell (hESC)-based therapy in man.”

The clearance had been blocked since last January after preliminary trials on animals resulted in the growth of small cysts in treated regions. Further testing led to the FDA’s recent approval.

Bishop Elio Sgreccia, who led the Pontifical Academy for Life for more than three years, told Vatican Radio in an interview released on Saturday that the use of human embryos in treatments should be rejected, “not only from the Catholic moral code but by whoever respects the human individual.”

Bishop Sgreccia noted that researchers carry out their experiments under the assertion that embryos remain only “a human being in the making.” But considering that embryos are “sacrificed” for the treatments, he said, “from an ethical point of view (it) can only receive a negative judgment.”

Looking at the results of embyronic stem cell testing, he said, it can be seen that, to date, the expected results have not been obtained. This, said Bishop Sgreccia, is due to the fact that embryonic stem cells are meant for the creation of a human being, not just other cells.



“In any case,” he added, “in the remote possibility that there was a positive result, morally it remains a crime.

Wednesday, July 28, 2010

Couric Brings Science and Ethics to Light



Katie Couric says we need to “find common ground between ethics and science, a compromise that everyone can live with and that might save lives”. Couric is right on. But her example into the bioethics of science is limited.

The ethics behind science is not limited to the ethical dilemma of using and funding human embryos for research. It has far reaching implications into other aspects of science.

Unfortunately these far-reaching implications are what the public does not quite yet understand. And it is dangerous ignorance.

Advanced technologies in nanotechnology, genetic engineering and synthetic biology are being developed and commercialized today at the expense of public health and safety. These technologies can also have dangerous and negative effects upon public. This is an ethical issue.

It is an ethical issue when science is advanced without appropriate risk assessment and safety protections for the public. It is an ethical issue when laws are made to prevent public transparency from understanding these issues or even preventing research into these safety aspects of advanced technologies. But it is happening today.

It doesn’t stop there. Ethics surrounding science is also about the loss of public rights with patenting of life, about scientists making profit off publically funded research, about conflicts of interests within academia, government and private industry which culminate into money making instead of life-saving research, about the public not having access to science publications that they fund, about how trade secrets supercede worker safety, public health and safety and human rights and about the lack of scientist’s rights to speak out regarding dangerous technologies that impact our health and society.

Ethical issues surrounding science are not being given adequate coverage in the media. And unfortunately when a scientific issue does get coverage, the coverage appears unbalanced, providing all the potential benefits of what science can offer, but then hardly ever providing the public a good understanding of the public safety and ethics involved.

Because the “ethical” issues underlying science are being put aside and even silenced in some cases, the public is slowly but surely losing more and more legal rights and human rights as technology advances. For example, we have lost the right to have our food properly labeled as genetically modified or not.

But the public should have the right to understand these ethical issues since they fund approximately $32 Billion dollars a year toward general biomedical research. That is a lot of money pulled from the taxpayer pocket.

Ethical issues related to science may not always be black or white. But they still deserve public transparency and debate since in some instance scientific technologies can create greater harm then good.

Couric is right in bringing to light the issue of balancing ethics and science. She is wrong, however, in limiting her ethical example to the embryonic stem cell, an issue that has historically been branded with divisiveness, extremism and propaganda, an issue that has caused a break in public awareness and adequate discussions in bioethics as a whole.

Nevertheless, Couric has to be acknowledged in hastening the public to be more aware of the importance of understanding the ethics behind science.

Saturday, December 5, 2009

Leadership, Power and Women

Leadership, Power and Women
Becky A. McClain
November 21, 2009

I find it ironic that in a crowded room full of women who had been lured to a talk entitled “Stepping into Power: How to Get it and How to Use It”, the lone person dozing off at the event was the only man in attendance.

Sponsored by a professional women networking group called the Lower Connecticut Valley Branch of the American Association of University Women (AAUW), the public event last Wednesday held in Old Saybrook’s Acton Library featured Dr. Nancy Hutson, a 25 year career Pfizer executive who had retired in 2006.

Hutson’s talk was advertized to discuss the subject of POWER – getting it and how to use it in the context of her experience as a woman during her career climb from a bench scientist to Senior Vice President in the male-dominated pharmaceutical organization at Pfizer Inc.

I was intrigued, not only because of the topic of power and how it relates to working women, but also, because of the past history of Pfizer and their use of power.

You see, Pfizer has not displayed the best reputation for getting and using power. In fact, Pfizer’s reputation has become seriously tarnished this past decade both locally and internationally. Their role in the imminent domain take over of New London homes, and subsequently bugging out of New London after their 10 year tax incentive deal expired, their role in public health and safety violations accompanied with research building explosions causing serious injuries, their role in unethical clinical trials resulting in deaths of Nigerian children, and finally, their egregious behavior in criminal fraud against the government for promotion of off-labeled use of their drugs are some of Pfizer’s most recent notorious acts, costing the company billions of dollars in criminal fines and settlements.

So how was Hutson going to deliver her topic on the use of power in light of what some could allege was a grand collection of abuse of power from Pfizer during her tenure?

But Hutson was slick to avoid such topics, as any savvy executive would.

And in the end her talk was disappointingly empty. Not only in her uncanny assertion that Pfizer’s bad reputation resulted from healthcare reform, baby boomers and bad economy, but also for her bland subject matter relating to power, women and her workplace experiences.

One would think that a woman who has climbed the corporate ladder of success at Pfizer from bench scientist to Senior Vice President in charge of 4500 Groton scientists would have SOME gripping stories to share, stories containing her trials and tribulations of being a woman within the highly charged political terrain of a male dominated pharmaceutical industry.

But Hutson’s worst experience shared with us was the time her supervisor performed email tasks while she was trying to have a discussion with him. Apparently her supervisor was not being completely “present” with her, making her feel discounted.

It was then when I turned to my side and noticed my husband beginning to nod off. And as I dug my elbow into his side to make him “be present”, I realized that Hutson did not even bother to tell us how she resolved the dilemma of having such a multi-tasking un-present supervisor.

Matter a fact, Hutson gave us very little insights about the true struggles women face in the workplace, like harassment, discrimination, glass ceilings, managing work and family, and unequal pay scales.

Instead she gave us an ordinary package of self-help steps to leadership, wrapped in jargon, ringing of mundane familiarity, …“Develop relationships”, “be present”, “manage your energy”, “practice leadership”, “have defined purpose, mission and goals”. Abracadabra. You’ve got power.

And of course, not a whisper of ethics. Hutson’s experience with ethics at Pfizer apparently had little connection in defining her steps in how to get power and use it.

Despite Hutson’s cookbook and carefully constructed talk, what was apparent, however, was at the conclusion of her presentation, you could not help but like Nancy Hutson.

And that’s because Hutson fits the part.

Nancy Hutson fits the part of our present day executives, people who look and act intelligent, self assured, but down to earth, and who have the ability to develop relationships because of their knack for the art of massaging communication. They are the type of person you seemingly could trust with any personal issue, a person that one would love to share a cup of coffee and perhaps become friends.

But in reality, many corporate execs who have “stepped into power” have often watched unethical practices unfold in their businesses. And while “practicing leadership”, standing composed and smiling, and carefully managing their energy and their speech, they do nothing, as well as, say nothing about these unethical practices.

You see, good executives deliver for their corporations, reporting to the bottom line. And that is exactly what Hutson told us on Wednesday. One of her opening statements was that her career role shifted from bench science to politics and the bottom line. Hutson went on to say that those who deliver for corporations are rewarded by power, title and money.

Hutson surely delivered for corporate America at the AAUW meeting. She was intelligent, articulate and friendly. She gave a well structured non-controversial talk, avoiding the tough issues women face in the workplace and avoiding Pfizer’s history of ethical troubles.

But a discussion about leadership and power, without involving ethics, sells cheap. It holds no real substance for the majority of professional women of Connecticut who want to succeed while making the world a better place.

And ironically, it put the only man attending such a discussion, right to sleep.